HIV infection
Not recruitingStudy on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
Study on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
- Disease:HIV infection
- Substances:Dolutegravir SodiumEmtricitabine+5
Spain- Participants:18–64 years · 65+ years
- Substances:Dolutegravir Sodium
- Sponsor:Fundacion Seimc Gesida












